Tomorrow at #
ESMO26#: MSK gastrointestinal medical oncologist
@AndreaCercek will present the first results from the global AZUR1 trial of dostarlimab monotherapy in patients with dMMR/MSI-H locally advanced rectal cancer.
๐๏ธ Sunday, October 25 | 11:00 a.m. CET